These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23261453)

  • 1. Conserved hydrogen bonds and water molecules in MDR HIV-1 protease substrate complexes.
    Liu Z; Wang Y; Yedidi RS; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1022-7. PubMed ID: 23261453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nine crystal structures determine the substrate envelope of the MDR HIV-1 protease.
    Liu Z; Wang Y; Brunzelle J; Kovari IA; Kovari LC
    Protein J; 2011 Mar; 30(3):173-83. PubMed ID: 21394574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystal structures of multidrug-resistant HIV-1 protease in complex with two potent anti-malarial compounds.
    Yedidi RS; Liu Z; Wang Y; Brunzelle JS; Kovari IA; Woster PM; Kovari LC; Gupta D
    Biochem Biophys Res Commun; 2012 May; 421(3):413-7. PubMed ID: 22469467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the mechanism of drug resistance: X-ray structure analysis of multi-drug resistant HIV-1 protease ritonavir complex.
    Liu Z; Yedidi RS; Wang Y; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC
    Biochem Biophys Res Commun; 2013 Feb; 431(2):232-8. PubMed ID: 23313846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structures of a multidrug-resistant human immunodeficiency virus type 1 protease reveal an expanded active-site cavity.
    Logsdon BC; Vickrey JF; Martin P; Proteasa G; Koepke JI; Terlecky SR; Wawrzak Z; Winters MA; Merigan TC; Kovari LC
    J Virol; 2004 Mar; 78(6):3123-32. PubMed ID: 14990731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-drug resistant HIV-1 protease is resistant to the dimerization inhibitory activity of TLF-PafF.
    Yedidi RS; Proteasa G; Martin PD; Liu Z; Vickrey JF; Kovari IA; Kovari LC
    J Mol Graph Model; 2014 Sep; 53():105-111. PubMed ID: 25108107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular dynamics study comparing a wild-type with a multiple drug resistant HIV protease: differences in flap and aspartate 25 cavity dimensions.
    Seibold SA; Cukier RI
    Proteins; 2007 Nov; 69(3):551-65. PubMed ID: 17623840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular basis for substrate recognition and drug resistance from 1.1 to 1.6 angstroms resolution crystal structures of HIV-1 protease mutants with substrate analogs.
    Tie Y; Boross PI; Wang YF; Gaddis L; Liu F; Chen X; Tozser J; Harrison RW; Weber IT
    FEBS J; 2005 Oct; 272(20):5265-77. PubMed ID: 16218957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystallographic study of multi-drug resistant HIV-1 protease lopinavir complex: mechanism of drug recognition and resistance.
    Liu Z; Yedidi RS; Wang Y; Dewdney TG; Reiter SJ; Brunzelle JS; Kovari IA; Kovari LC
    Biochem Biophys Res Commun; 2013 Jul; 437(2):199-204. PubMed ID: 23792096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and evaluation of a potent substrate analog inhibitor identified by scanning Ala/Phe mutagenesis, mimicking substrate co-evolution, against multidrug-resistant HIV-1 protease.
    Yedidi RS; Muhuhi JM; Liu Z; Bencze KZ; Koupparis K; O'Connor CE; Kovari IA; Spaller MR; Kovari LC
    Biochem Biophys Res Commun; 2013 Sep; 438(4):703-8. PubMed ID: 23921229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural implications of drug-resistant mutants of HIV-1 protease: high-resolution crystal structures of the mutant protease/substrate analogue complexes.
    Mahalingam B; Louis JM; Hung J; Harrison RW; Weber IT
    Proteins; 2001 Jun; 43(4):455-64. PubMed ID: 11340661
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substrate shape determines specificity of recognition for HIV-1 protease: analysis of crystal structures of six substrate complexes.
    Prabu-Jeyabalan M; Nalivaika E; Schiffer CA
    Structure; 2002 Mar; 10(3):369-81. PubMed ID: 12005435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resilience to resistance of HIV-1 protease inhibitors: profile of darunavir.
    Lefebvre E; Schiffer CA
    AIDS Rev; 2008; 10(3):131-42. PubMed ID: 18820715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism of substrate recognition by drug-resistant human immunodeficiency virus type 1 protease variants revealed by a novel structural intermediate.
    Prabu-Jeyabalan M; Nalivaika EA; Romano K; Schiffer CA
    J Virol; 2006 Apr; 80(7):3607-16. PubMed ID: 16537628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catalytic water co-existing with a product peptide in the active site of HIV-1 protease revealed by X-ray structure analysis.
    Prashar V; Bihani S; Das A; Ferrer JL; Hosur M
    PLoS One; 2009 Nov; 4(11):e7860. PubMed ID: 19924250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ligand modifications to reduce the relative resistance of multi-drug resistant HIV-1 protease.
    Dewdney TG; Wang Y; Liu Z; Sharma SK; Reiter SJ; Brunzelle JS; Kovari IA; Woster PM; Kovari LC
    Bioorg Med Chem; 2013 Dec; 21(23):7430-4. PubMed ID: 24128815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How Mutations Can Resist Drug Binding yet Keep HIV-1 Protease Functional.
    Appadurai R; Senapati S
    Biochemistry; 2017 Jun; 56(23):2907-2920. PubMed ID: 28505418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the substrate-envelope hypothesis: structural analysis of novel HIV-1 protease inhibitors designed to be robust against drug resistance.
    Nalam MN; Ali A; Altman MD; Reddy GS; Chellappan S; Kairys V; Ozen A; Cao H; Gilson MK; Tidor B; Rana TM; Schiffer CA
    J Virol; 2010 May; 84(10):5368-78. PubMed ID: 20237088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic profiling of substrate binding response to multidrug-resistant mutations in HIV-1 protease: Implication for combating drug resistance.
    Lv Y; Li J; Fang J; Jiao X; Yan L; Shan B
    J Mol Graph Model; 2017 Jun; 74():83-88. PubMed ID: 28371730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural, kinetic, and thermodynamic studies of specificity designed HIV-1 protease.
    Alvizo O; Mittal S; Mayo SL; Schiffer CA
    Protein Sci; 2012 Jul; 21(7):1029-41. PubMed ID: 22549928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.